We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Product Recall for 3M™ Heavy Duty Breathing Tubes presenting a health risk.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Form (R1) for identification of legionella, mycoplasma, ureaplasma and respiratory chlamydia.
Managing acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs) and in the Children and Young People Secure Estate (CYPSE).
Guidance, resources and information for professionals about respiratory viruses.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Alert issued an alert to advise of a case of a novel coronavirus in a patient receiving treatment in a London hospital.
Guidance on investigating Middle East respiratory syndrome coronavirus (MERS-CoV), public health management of suspected UK cases and advice to travellers.
Advice for medical professionals to follow when assessing drivers with renal and respiratory disorders.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Healthcare professionals prescribing nitrofurantoin should be alert to the risks of pulmonary and hepatic adverse drug reactions and advise patients to be vigilant for the signs and symptoms in need of further investigation.
This consultation asks for feedback on UK Standards for Microbiology Investigations V 58: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
These documents provide advice on the symptoms, diagnosis, treatment, management and epidemiology of respiratory syncytial virus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.